TCF12 is a basic helix-loop-helix transcription factor located on chromosome 15 that functions as a sequence-specific DNA-binding transcriptional activator 1. It binds E-box elements (5'-CANNTG-3') and regulates transcription through RNA polymerase II 2. TCF12 plays critical roles in neurodevelopmental and craniofacial processes: it initiates neuronal differentiation and participates in functional networks regulating GnRH axis development 2. In hematopoietic stem cells, nuclear TCF12 cooperates with nuclear tubulin to enhance CXCR4 transcription and promote chemotaxis 3. Pathogenic TCF12 variants cause monogenic developmental disorders. De novo mutations associate with neurodevelopmental disorders and intellectual disability 24, and loss-of-function variants increase cancer risk in congenital heart disease patients 5. Most notably, TCF12 mutations are a significant genetic cause of coronal craniosynostosis, accounting for approximately 10-20% of cases negative for TWIST1 and FGFR variants, with estimated prevalence of 2% in undifferentiated craniosynostosis cohorts 6. TCF12 also associates with hypogonadotropic hypogonadism with or without anosmia. In colorectal cancer, the TCF12-MALAT1 regulatory alliance modulates cyclin D1 and β-catenin expression patterns affecting prognosis independently of metastasis 7, suggesting TCF12 has context-dependent roles in development and disease.